Evidence map›Paper›PMID 39519184›Full record

ArticleInternational journal of molecular sciences2024

Safety of Zein Nanoparticles on Human Innate Immunity and Inflammation.

Annunziata Corteggio, Tommaso Heinzl, Diana Boraschi, Silvia Voci, Agnese Gagliardi, Donato Cosco, Paola Italiani

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Annunziata CorteggioInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Napoli, Italy.
Tommaso HeinzlInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Napoli, Italy.
Diana BoraschiInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Napoli, Italy.ORCID 0000-0002-3953-4056
Silvia VociDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "Salvatore Venuta", 88100 Catanzaro, Italy.
Agnese GagliardiDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "Salvatore Venuta", 88100 Catanzaro, Italy.
Donato CoscoDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "Salvatore Venuta", 88100 Catanzaro, Italy.ORCID 0000-0002-4898-0365
Paola ItalianiInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Napoli, Italy.ORCID 0000-0001-9830-2733

Funding

Bill and Melinda Gates Foundation INV-059115European Commission H2020 EU GA671881European Commission H2020 GA 812661Key Collaborative Research Program of the Alliance of International Science Organizations ANSO-CR-KP-2022-01Ministero dell'Istruzione e del Merito 20173ZECCMNSFC-MAECI 82261138630
6 · The paper itself

Abstract

In recent years, natural polymers have attracted great interest for the development of release systems for vaccine formulations and drug delivery. Zein, a hydrophobic proline-rich protein mixture obtained from maize, is one of the most widely used polymers, very promising for applications in tissue engineering and the parenteral delivery of bioactive agents. Still, we have a limited understanding of the interaction between zein particles and the human immune system, in particular innate immunity/inflammation, which is the first line of defense of our body. Assessing the immune safety of nanoparticles is of central importance for ensuring that nano-formulations for medical use do not cause adverse effects on human health. Here, we evaluated the capacity of zein nanoparticles to induce/modulate the innate/inflammatory response, the development of innate memory, and the macrophage polarization by using reliable in vitro systems based on human primary monocytes and monocyte-derived macrophages. We observed that zein nanoparticles do not influence any of these aspects of the innate immune/inflammatory response, suggesting its safety and its potential efficiency as a nanocarrier for drug or antigen delivery.

Indexed as

Immunity, InnateInflammationNanoparticlesZeinCells, CulturedHumansMacrophagesMonocytesZeininnate immunityinnate memorymacrophage polarizationnanoparticleszein

Identifiers

PMID39519184
PMCPMC11546227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.